Molecular Partners AG
SIX:MOLN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Molecular Partners AG
SIX:MOLN
|
CH |
|
Ebusco Holding NV
AEX:EBUS
|
NL |
|
Safilo Group SpA
MIL:SFL
|
IT |
|
S
|
SUMBER ENERGI ANDALAN Tbk PT
IDX:ITMA
|
ID |
|
CompuMed Inc
OTC:CMPD
|
US |
|
M
|
McDonald's Corp
SGO:MCD
|
US |
|
F
|
FlexQube AB (publ)
STO:FLEXQ
|
SE |
|
ePlus inc
NASDAQ:PLUS
|
US |
|
Iteos Therapeutics Inc
NASDAQ:ITOS
|
US |
|
Beam Global
NASDAQ:BEEM
|
US |
|
Ethema Health Corp
OTC:GRST
|
US |
Wall St Price Targets
MOLN Price Targets Summary
Molecular Partners AG
According to Wall Street analysts, the average 1-year price target for
MOLN is 10.58 CHF with a low forecast of 6.57 CHF and a high forecast of 15.75 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MOLN's stock price target?
Price Target
10.58
CHF
According to Wall Street analysts, the average 1-year price target for
MOLN is 10.58 CHF with a low forecast of 6.57 CHF and a high forecast of 15.75 CHF.